Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine Read more
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA Read more
Exclusive Speaker Interview with Nagy Habib, Imperial College London & MiNA Therapeutics Released ahead of the RNA Therapeutics Conference 2022 Read more
Verseau Therapeutics Announces FDA Clearance of Investigational New Drug Application for VTX-0811, a PSGL-1 Monoclonal Antibody Read more
Genprex Receives FDA Fast Track Designation for REQORSA Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer Read more
Pfizer and BioNTech Receive FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older Read more